Novavax Nuvaxovid COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older – Novavax Investor Relations
admin | September 18, 2022
Novavax Nuvaxovid COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older GAITHERSBURG, Md., Sept. 16, 2022 /PRNewswire/ -- Novavax,Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Israel Ministry of Health has granted an import and use permit which provides individuals aged 12 and older access to the Nuvaxovid (NVX-CoV2373) COVID-19 vaccine foractive immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a primary series and as a heterologous booster for those previously vaccinated with mRNA vaccines
